Kathryn Whitehead
Kathryn Ann Whitehead | |
|---|---|
| Born | 1980 (age 45–46) |
| Alma mater | University of Delaware University of California, Santa Barbara |
| Scientific career | |
| Institutions | Koch Institute for Integrative Cancer Research Carnegie Mellon University |
| Thesis | Safe and effective methods for improving the oral delivery of macromolecules (2007) |
| Website | http://whitehead.cheme.cmu.edu |
Kathryn Ann Whitehead (born 1980) is an American chemical engineer who is a professor at Carnegie Mellon University. Her research focuses on the engineering of nanomaterial-based drug delivery systems for gene therapy, oral macromolecular delivery systems, and maternal and infant therapeutics. She was elected as a Fellow of the American Institute for Medical and Biological Engineering in 2021 and as Fellow of the Controlled Release Society.